The efficacy of human papillomavirus prophylactic vaccination after conization in preventing cervical intraepithelial neoplasia recurrence: A prospective observational …

M Chen, C Li, Q Cui, C Zhou, P Chen, S Yao - European Journal of …, 2023 - Elsevier
High-risk human papillomavirus (hrHPV) infection is the cause of most cervical cancers.
Since therapeutic vaccines are not yet available for clinical practice, the administration of …

Safety of intralesional cidofovir in patients with recurrent respiratory papillomatosis: an international retrospective study on 635 RRP patients

REA Tjon Pian Gi, T Ilmarinen… - European Archives of …, 2013 - Springer
Intralesional use of cidofovir (Vistide®) has been one of the mainstays of adjuvant therapy in
patients with recurrent respiratory papillomatosis (RRP) since 1998. In 2011, a …

Effect of human papillomavirus vaccine to interrupt recurrence of vulvar and anal neoplasia (VIVA): a trial protocol

HCS Karita, K Hauge, A Magaret, C Mao… - JAMA network …, 2019 - jamanetwork.com
Importance Human papillomavirus (HPV), particularly HPV type 16, causes most anal and
vulvar high-grade squamous intraepithelial lesions (HSIL), which are precursors to cancer …

[HTML][HTML] Imiquimod versus podophyllotoxin, with and without human papillomavirus vaccine, for anogenital warts: the HIPvac factorial RCT.

R Gilson, D Nugent, K Bennett, CJ Doré… - Health Technology …, 2020 - ncbi.nlm.nih.gov
BACKGROUND The comparative efficacy, and cost-effectiveness, of imiquimod or
podophyllotoxin cream, either alone or in combination with the quadrivalent HPV vaccine …

[HTML][HTML] HPV vaccination: the position paper of the Italian society of colposcopy and cervico-vaginal pathology (SICPCV)

A Ciavattini, L Giannella, R De Vincenzo… - Vaccines, 2020 - mdpi.com
Human papillomavirus (HPV) related cervical cancer represents an issue of public health
priority. The World Health Organization recommended the introduction of HPV vaccination in …

Impact of the quadrivalent HPV vaccine on disease recurrence in men exposed to HPV Infection: a randomized study

ER Coskuner, TA Ozkan, A Karakose… - The journal of sexual …, 2014 - academic.oup.com
Introduction Human papillomavirus (HPV) is one of the most common sexually transmitted
infections and is the cause of several different diseases in men and women. Although little is …

[HTML][HTML] HPV prophylactic vaccination in males improves the clearance of semen infection

C Foresta, A Garolla, S Parisi, M Ghezzi, A Bertoldo… - …, 2015 - thelancet.com
Background Semen represents a reservoir for human papillomavirus (HPV), rising concern
in couples eligible for assisted reproduction techniques (ART). Humoral immunity against …

current knowledge on the role of HPV antibodies after natural infection and vaccination: implications for monitoring an HPV vaccination programme

M Mollers, JM Vossen, M Scherpenisse… - Journal of medical …, 2013 - Wiley Online Library
Abstract In 2006/2007, two vaccines were licensed against two of the most common HPV
types that cause about 70% of cervical cancers. Clinical trials show that vaccinated …

[HTML][HTML] Regression rate of high-grade cervical intraepithelial lesions in women younger than 25 years

A Ehret, VN Bark, A Mondal, TN Fehm… - Archives of gynecology …, 2023 - Springer
Background/purpose The incidence and clinical course of high-grade cervical intraepithelial
lesions (CIN 2/3) are age dependent. In CIN 3, the recommended treatment is conization …

[HTML][HTML] Can adjuvant HPV vaccination be helpful in the prevention of persistent/recurrent cervical dysplasia after surgical treatment?—a literature review

K Michalczyk, M Misiek, A Chudecka-Głaz - Cancers, 2022 - mdpi.com
Simple Summary Primary prophylactic, early detection and the treatment of precancerous
lesions are the main goals of cervical cancer screening. Despite effective surgical treatment …